Meeting
2021 ASCO Annual Meeting
Clinical performance of methylation-based liquid biopsy test COLVERA after optimization of test interpretation rules.
Authors
Zivjena Vucetic
Clinical Genomics, Bridgewater, NJ
Zivjena Vucetic , Naima Loayza , Susanne Kartin Pedersen , Missy Tuck , Lawrence Charles LaPointe
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3546)
DOI
10.1200/JCO.2021.39.15_suppl.3546
Abstract #
3546
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Post-treatment detection of circulating methylated BCAT1 and IKZF1 as prognostic indicators for recurrence in patients with colorectal cancer.
First Author: Graeme P. Young
Poster
2016 Gastrointestinal Cancers Symposium
A novel 2-gene blood test for colorectal cancer recurrence.
First Author: Susanne Kartin Pedersen
Poster
2022 ASCO Gastrointestinal Cancers Symposium
A single-center comparative surveillance strategies of ctDNA (Signatera), imaging, and CEA in the surveillance of resected colorectal cancer.
First Author: Jaideep Singh Sandhu
Poster
2021 ASCO Annual Meeting
Use of circulating tumor DNA in colorectal cancer patients to assess tumor burden and response to therapy: An observational study.
First Author: Erin L. Symonds